The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations
Open Access
- 12 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 22 (18), 3667-3679
- https://doi.org/10.1093/hmg/ddt216
Abstract
Pulmonary arterial hypertension (PAH) is characterized by dysregulated pulmonary artery endothelial cell (PAEC) proliferation, apoptosis and permeability. Loss-of-function mutations in the bone morphogenetic protein receptor type-II (BMPR-II) are the most common cause of heritable PAH, usually resulting in haploinsufficiency. We previously showed that BMPR-II expression is regulated via a lysosomal degradative pathway. Here, we show that the antimalarial drug, chloroquine, markedly increased cell surface expression of BMPR-II protein independent of transcription in PAECs. Inhibition of protein synthesis experiments revealed a rapid turnover of cell surface BMPR-II, which was inhibited by chloroquine treatment. Chloroquine enhanced PAEC expression of BMPR-II following siRNA knockdown of the BMPR-II transcript. Using blood outgrowth endothelial cells (BOECs), we confirmed that signalling in response to the endothelial BMPR-II ligand, BMP9, is compromised in BOECs from patients harbouring BMPR-II mutations, and in BMPR-II mutant PAECs. Chloroquine significantly increased gene expression of BMP9-BMPR-II signalling targets Id1, miR21 and miR27a in both mutant BMPR-II PAECs and BOECs. These findings provide support for the restoration of cell surface BMPR-II with agents such as chloroquine as a potential therapeutic approach for heritable PAH.This publication has 53 references indexed in Scilit:
- Identification of a Lysosomal Pathway Regulating Degradation of the Bone Morphogenetic Protein Receptor Type IIOnline Journal of Public Health Informatics, 2010
- Smad Proteins Bind a Conserved RNA Sequence to Promote MicroRNA Maturation by DroshaMolecular Cell, 2010
- Cytoplasmic phospholipase A2 antagonists inhibit multiple endocytic membrane trafficking pathwaysBiochemical and Biophysical Research Communications, 2009
- FRET Reveals Novel Protein-Receptor Interaction of Bone Morphogenetic Proteins Receptors and Adaptor Protein 2 at the Cell SurfaceBiophysical Journal, 2009
- Cellular and Molecular Basis of Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2009
- Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial CellsOnline Journal of Public Health Informatics, 2009
- SMAD proteins control DROSHA-mediated microRNA maturationNature, 2008
- Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic ImplicationsJournal of Pharmaceutical Sciences, 2007
- Different Routes of Bone Morphogenic Protein (BMP) Receptor Endocytosis Influence BMP SignalingMolecular and Cellular Biology, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001